GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (FRA:OB3) » Definitions » Cash per Share

OptiBiotix Health (FRA:OB3) Cash per Share : €0.02 (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is OptiBiotix Health Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). OptiBiotix Health's Cash per Share for the quarter that ended in Jun. 2024 was €0.02.


OptiBiotix Health Cash per Share Historical Data

The historical data trend for OptiBiotix Health's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health Cash per Share Chart

OptiBiotix Health Annual Data
Trend Jul12 Nov14 Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22 Dec23
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.01 0.03 0.01 0.01

OptiBiotix Health Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.01 0.01 0.02

OptiBiotix Health Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

OptiBiotix Health's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

OptiBiotix Health's Cash per Share for the quarter that ended in Jun. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OptiBiotix Health  (FRA:OB3) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


OptiBiotix Health Cash per Share Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiBiotix Health Business Description

Traded in Other Exchanges
Address
Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.

OptiBiotix Health Headlines

No Headlines